Frank Waligora

VP, Technical Operations

Professional Overview
Frank Waligora is an experienced pharmaceutical executive with a strong track record in technical operations, manufacturing, and quality control. As the VP of Technical Operations at Curis, he oversees all aspects of the company's manufacturing and supply chain, ensuring the efficient and compliant production of critical drug products.

Experience Summary

Current Role
In his current role as VP of Technical Operations at Curis, Frank is responsible for managing the company's technical operations, including production, quality assurance, and supply chain logistics. He has been instrumental in streamlining manufacturing processes, improving operational efficiency, and ensuring the timely delivery of Curis' drug candidates to clinical trial sites and patients.

Career Progression
Frank has over 25 years of experience in the pharmaceutical industry, having held various leadership positions at top-tier companies. Prior to his current role, he served as the VP of Technical Operations at Imara, Inc., where he played a crucial role in the company's successful clinical development and regulatory approval process. Before that, he held the position of VP of CMC at Curis, managing the company's chemistry, manufacturing, and controls functions. Earlier in his career, Frank held director-level roles at Idera Pharmaceuticals and ZIOPHARM Oncology, Inc., where he contributed to the advancement of their drug pipelines.

Academic Background
Frank holds a Bachelor of Science degree in Chemistry from the University of North Carolina at Chapel Hill. He has also completed advanced training in pharmaceutical manufacturing and quality management.

Areas of Expertise

• Pharmaceutical manufacturing and supply chain management

• Quality assurance and regulatory compliance

• CMC (chemistry, manufacturing, and controls) strategy

• Project management and cross-functional team leadership

• Operational efficiency and process optimization

Professional Impact
During his tenure at Imara, Inc., Frank led the successful completion of the company's first Phase 3 clinical trial, overseeing the seamless coordination of the global manufacturing and distribution network. At Curis, he has spearheaded initiatives to enhance the company's manufacturing capabilities, resulting in improved product quality, reduced costs, and faster time-to-market.

Conclusion
With his extensive experience and expertise in technical operations, Frank Waligora is a valuable asset to the Curis team. His commitment to driving operational excellence and delivering high-quality drug products aligns closely with the company's mission to improve the lives of patients. As Curis continues to advance its pipeline, Frank's leadership and strategic vision will be instrumental in navigating the challenges of the pharmaceutical industry and achieving the company's long-term goals.